NCT00165737View on ClinicalTrials.gov

Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

974

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

August 31, 2005

Study Completion Date

June 30, 2006

Conditions
Dementia, Vascular
Interventions
DRUG

Donepezil Hydrochloride

Trial Locations (5)

12208

Neurological Associate of Albany PC, Albany

33702

Comprehensive Neuroscience, St. Petersburg

61637

St. Francis Medical Center, Peoria

71913

Central Arkansas Research (CARE), Hot Springs

77030

University of Texas Mental Sciences Institute, Houston

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00165737 - Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease | Biotech Hunter | Biotech Hunter